- Accueil >
 - Publications >
 - Long term HER2+ metastatic breast cancer survivors treated by trastuzumab: Results from the French cohort study LHORA
 
Long term HER2+ metastatic breast cancer survivors treated by trastuzumab: Results from the French cohort study LHORA
Auteurs
J.-P. Spano, P. Beuzeboc, D. Coeffic, L. Arnould, A. Lortholary, F. Andre, J.-M. Ferrero